Literature DB >> 15134111

Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal.

M Stefaniotou1, M Aspiotis, C Kalogeropoulos, A Christodoulou, M Psylla, E Ioachim, I Alamanos, K Psilas.   

Abstract

PURPOSE: To determine whether vitrectomy for diffuse diabetic macular edema with and without internal limiting membrane (ILM) peeling is equally effective in reducing edema.
METHODS: The authors retrospectively analyzed the surgical outcomes in 73 eyes of 52 patients with diffuse diabetic macular edema. Eighteen eyes (Group A) underwent three-port pars plana vitrectomy with posterior hyaloid membrane (PHM) removal, while 55 eyes (Group B) had pars plana vitrectomy with additional ILM peeling after PHM removal.
RESULTS: Intraoperatively, the posterior hyaloid was found to be attached to the macula in all eyes. In Group A, macular edema resolved completely in 8 eyes (44.4%) with improvement of visual acuity (VA). In Group B, VA improved in 38 eyes (69.1%) with complete resolution of edema. The results of this study indicated that vitrectomy effectively reduced macular edema but eyes with ILM peeling (Group B) presented better results than those without ILM peeling. Another important factor related to the outcome seems to be the level of glycosylated hemoglobin (HbA1c).
CONCLUSIONS: In eyes with diffuse diabetic macular edema vitrectomy seems to be effective, but additional ILM peeling presented better results.

Entities:  

Mesh:

Year:  2004        PMID: 15134111     DOI: 10.1177/112067210401400209

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  18 in total

1.  Pars plana vitrectomy with internal limiting membrane removal for macular hole associated with proliferative diabetic retinopathy.

Authors:  Toshihide Kurihara; Kousuke Noda; Susumu Ishida; Makoto Inoue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-19       Impact factor: 3.117

2.  Kallikrein-kinin activation by altered vitreous pH: New perspectives for treatment and pathogenesis of diabetic macular edema? : Comment on: Gao BB et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007 Feb;13(2):181-8.

Authors:  O Zeitz; M Keserü
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-06       Impact factor: 3.117

3.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

4.  Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a Meta-analysis.

Authors:  Xin-Ying Hu; Huan Liu; Li-Na Wang; Yu-Zhi Ding; Jie Luan
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

5.  Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.

Authors:  Mehmet Bahadir; Aylin Ertan; Ozgür Mertoğlu
Journal:  Int Ophthalmol       Date:  2006-06-19       Impact factor: 2.031

6.  Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.

Authors:  Lauren M Marozas; Patrice E Fort
Journal:  US Ophthalmic Rev       Date:  2014

7.  Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema.

Authors:  Jan Kalvoda; Jaroslava Dusková; Ales Kubena; Ctibor Povýsil; Bohdana Kalvodová
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-09       Impact factor: 3.117

Review 8.  Visualizing vitreous in vitrectomy by triamcinolone.

Authors:  Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-20       Impact factor: 3.117

9.  Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial.

Authors:  Hans Hoerauf; Anne Brüggemann; Manuela Muecke; Julia Lüke; Maya Müller; Einar Stefánsson; Hans-Peter Hammes; Claudia Weiss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-18       Impact factor: 3.117

10.  Pars plana vitrectomy with internal limiting membrane peeling for refractory diffuse diabetic macular edema.

Authors:  Mohammad-Hossein Dehghan; Masoud Salehipour; Jalil Naghib; Mahnaz Babaeian; Saeed Karimi; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.